Product
Newsroom
Evidence
Blog
About Us
About Us
Careers & Culture
Contact
Media
August 31, 2023
Truvian Progresses on Blood Testing Benchtop
July 27, 2023
Truvian’s blood testing platform provides lab quality results
October 22, 2021
Thera-who? These Biotech Firms are Looking to Push What’s Possible with Blood
September 4, 2021
Silicon Valley Still Believes in Promise of Easy Blood Tests Despite Theranos Scandal
August 30, 2021
Truvian CEO: Theranos’ One Drop Blood Testing ‘Was Always Science Fiction’
August 28, 2021
Theranos Didn’t Stop the Search for the Next Healthcare Star
August 26, 2021
The Prospects, Prominence, Possibilities of Point-of-Care Testing
March 12, 2021
Beyond Bad Blood: Healthtech Startup Truvian Hopes to Succeed Where Theranos Failed
March 2, 2021
Truvian Sciences Receives $105 Million Series C Funding
February 24, 2021
Truvian Sciences Raises $105M Series C to Fund Development of Point-of-Care Testing Platform
February 24, 2021
No More Waiting for Central Lab Results: Truvian Raises $105M
February 24, 2021
Truvian Raises $105M, Plans to Submit Benchtop Blood-Testing Tech to FDA
February 24, 2021
Truvian Sciences Raises More Than $105M in Series C Financing
February 24, 2021
Truvian Closes $105M Series C Financing Round
February 24, 2021
San Diego’s Truvian Sciences Raises $105M to Bring Common Wellness Blood Tests Closer to Home
February 24, 2021
Truvian Sciences Snares $105M for its Many-in-One Blood Testing Machine
February 24, 2021
Truvian Closes $105M Oversubscribed Series C
February 19, 2021
Empowering Consumers with Point-of-Care Blood Testing
February 3, 2021
Women Make Notable Gains in Local STEM Workforce
January 20, 2021
New Technology, Vaccine Availability Reshaping Hospital Care
January 11, 2021
COVID-19 Pandemic Accelerates Adoption of Diagnostic Testing at Point of Care
December 21, 2020
AACC 2020: COVID-19 Paved Way For ‘Retailization,’ Innovation In Point-Of-Care Testing, Now What?
September 14, 2020
San Diego’s White-Collar Workers Are Still in Limbo, but Some Eyeing a Return to the Office
September 14, 2020
OC Startups Now
September 2, 2020
Forbes Feature: The Pandemic Can Drive Healthcare Reform
August 4, 2020
Founders’ Story: Truvian Sciences
March 25, 2020
Truvian Sciences’ Point-of-Care Diagnostics Could Provide Long-Term Solution for Future Pandemics
January 27, 2020
True Blood? In the Shadow of Theranos, Truvian Revives Dream of Low-Cost Blood Tests
December 30, 2019
ABC 10 News San Diego – KGTV Feature
December 23, 2019
Company Developing 5-Drop, 20-Minute Blood Test
December 20, 2019
Blood Testing Nears a Turning Point as the Evidence Becomes Undeniable
December 10, 2019
Truvian Sciences Moves Closer to Commercialization of Benchtop Blood Testing System
December 3, 2019
Truvian Seeks to Decentralize Blood Testing
November 27, 2019
Health Tech Funding Snapshot—Sony Joins $42M Round in Endoscopy AI Company; Wellframe Raises $20M
November 26, 2019
Health and Life Science Deals
November 24, 2019
Funding Goes to Cancer Drug Developers, Company Billed as the Anti-Theranos
November 22, 2019
Truvian Sciences Raises $27m As It Tries To Succeed Where Theranos Failed
November 21, 2019
Truvian Sciences Looks to Disrupt Dx Market With Three-Modality Platform
November 21, 2019
Theranos-like Blood-testing Startup Raises $27m
November 20, 2019
Blood Test Startup Truvian Sciences Closes $27M Series B Financing Round
November 20, 2019
Truvian Nets $27m To Build Its Comprehensive Benchtop Blood Testing Machine
November 20, 2019
Truvian Sciences Raises $27.1m For A Testing System Needing Only “A Small Sample Of Blood”
November 20, 2019
With Echoes Of Theranos, Truvian Sciences Revives The Dream Of Low-cost, Accessible Blood Tests
November 20, 2019
Blood-Testing Startup Truvian Raises Fresh Capital
November 20, 2019
Great Point Ventures Leads Series B Round For Truvian Sciences